Taiwan Job Opening, OFW Taiwan News, Taiwan Labor Laws, Taiwan News

Cancer Causing Blood Pressure Medication Recalled By Pharmaceutical Firms In Taiwan


Potential carcinoges have been found to some blood pressure medications coming from local pharmaceutical firms that issues recalls of the medication tablets.

Valsartan a coming from Taipei based Synmosa Biopharma Corp, Synpac Kingdom Pharmaceutical and China based Tianyu Pharmaceutical have discovered an active ingredient in the medication that contained N-nitrosodimethylamine (NDMA) according to reports.

Valsatran with 80mg and 160mg are used to prevent high blood pressure while the ingredient NDMA will likely to cause cancer according to Food and Drug Administration of Taiwan.

There are a total of 660 million tablets that have been recalled that can lead to a cancerous disease. There were also the same incidents reported worldwide that contain the same ingredient in high blood pressure medications.
Share:

0 comments:

Post a Comment